Foundayo Tab 14.5mg x 30

Foundayo 14.5mg film-coated tablets contain orforglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. It is a prescription-only medicine authorised in the UK for weight management in eligible adults and to improve glycaemic control in adults with insufficiently controlled type 2 diabetes.

Foundayo works by activating GLP-1 receptors involved in appetite regulation and glucose control. For weight management, it is used alongside a reduced-calorie diet and increased physical activity. The 14.5mg strength is one of several available strengths, and treatment must follow the individual prescribing clinician’s instructions.

Delivery and Returns

SKU: SK-01069 Category: Tags: , Brands:

Benefits

  • Oral GLP-1 treatment: A tablet formulation containing orforglipron.
  • Weight management: Indicated for eligible adults alongside dietary and physical activity changes.
  • Blood glucose control: Also authorised for adults with insufficiently controlled type 2 diabetes.
  • Once-daily formulation: Taken according to the prescribing clinician’s instructions.
  • Established product information: Supplied with official prescribing and patient information.

Features

  • Active ingredient: Orforglipron
  • Strength: 14.5mg per tablet
  • Pack size: 30 film-coated tablets
  • Administration: Oral
  • Food restrictions: May be taken with or without food, at any time of day.
  • Treatment approach: Used alongside appropriate lifestyle measures for weight management and diabetes care.
  • Prescription status: Prescription-only medicine.

Why Choose

Foundayo provides an oral treatment option for eligible adults requiring medical management of weight or type 2 diabetes. Its active ingredient, orforglipron, acts on GLP-1 receptors involved in appetite regulation and glucose metabolism.

The 14.5mg tablet is one strength within a dose range that allows prescribing clinicians to individualise treatment according to response and tolerability. Patients should follow their prescribed treatment plan and consult their healthcare professional before making any changes.

Common Uses

Weight management: Used alongside a reduced-calorie diet and increased physical activity in adults with a BMI of 30kg/m² or above, or a BMI of 27–29.9kg/m² with at least one weight-related health condition.

Type 2 diabetes: Used alongside diet and exercise to improve blood glucose control in adults whose type 2 diabetes is insufficiently controlled, either as monotherapy when metformin is inappropriate or in combination with other diabetes medicines, as clinically appropriate.

How It Works

Foundayo contains orforglipron, a non-peptide GLP-1 receptor agonist. It activates GLP-1 receptors involved in appetite regulation and glucose metabolism.

Its effects include reducing food intake, supporting weight reduction and improving blood glucose control. It also delays gastric emptying, particularly following the first dose, with this effect diminishing over time.

Foundayo should be used only as prescribed and alongside the lifestyle measures recommended by the treating healthcare professional.

What is Foundayo 14.5mg used for?
Foundayo is authorised for weight management in eligible adults and for improving glycaemic control in adults with insufficiently controlled type 2 diabetes. It is used alongside the relevant diet and physical activity measures.
What is the active ingredient in Foundayo?
The active ingredient is orforglipron, an oral GLP-1 receptor agonist.
How is Foundayo taken?
Foundayo is taken orally once daily, at any time of day, with or without food. Tablets should be swallowed whole and must not be crushed, chewed or broken. Patients must follow their prescribed dose and must not change it without advice from their prescriber.
Is Foundayo 14.5mg a starting dose?
No. The authorised dose schedule begins at a lower strength and may be increased gradually at intervals of at least 30 days, according to treatment response and tolerability. The 14.5mg strength is intended for use within this prescribed dose-escalation schedule, not as an automatic starting dose.

Related products